1
|
Mendas I, Gastaldi S, Suppo JS. Strategies for Accessing cis-1-Amino-2-Indanol. Molecules 2024; 29:2442. [PMID: 38893318 PMCID: PMC11173559 DOI: 10.3390/molecules29112442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Revised: 05/14/2024] [Accepted: 05/15/2024] [Indexed: 06/21/2024] Open
Abstract
cis-1-amino-2-indanol is an important building block in many areas of chemistry. Indeed, this molecule is currently used as skeleton in many ligands (BOX, PyBOX…), catalysts and chiral auxiliaries. Moreover, it has been incorporated in numerous bioactive structures. The major issues during its synthesis are the control of cis-selectivity, for which various strategies have been devised, and the enantioselectivity of the reaction. This review highlights the various methodologies implemented over the last few decades to access cis-1-amino-2-indanol in racemic and enantioselective manners. In addition, the various substitution patterns on the aromatic ring and their preparations are listed.
Collapse
|
2
|
Jouffroy M, La Torre M, Maton W, Cleator E. Pd/C Catalyzed Dehalogenation of (Hetero)aryls Using Triethylsilane as Hydrogen Donor. SYNTHESIS-STUTTGART 2023. [DOI: 10.1055/s-0042-1753402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
Abstract
Abstract(Hetero)aryl dehalogenation is a classical transformation usually performed using hydrogen gas and a metal supported on carbon, notably palladium (Pd/C). Though efficient, the need for a milder and operationally simple dehalogenation can arise. We found that the combination of Pd/C as catalyst and triethylsilane (TES) as hydrogen donor in THF resulted in a broadly applicable, easy to set up, and scalable debromination and deiodination. Optimization of the reaction showed that 1 mol% of Pd/C and 4 equiv of TES at room temperature were sufficient to obtain full conversion of most synthons of pharmaceutical interest in 4–24 h. The newly found conditions were applied to a large range of aromatic and heteroaromatic substrates, affording the desired targets in good to excellent yields with an exceptional functional group tolerance.
Collapse
Affiliation(s)
- Matthieu Jouffroy
- Chemical Process R&D, Discovery Process Research, Janssen Pharmaceutica N.V
| | - Mathéo La Torre
- Chemical Process R&D, Discovery Process Research, Janssen Pharmaceutica N.V
| | - William Maton
- Chemical Process R&D, External R&D Capabilities, Janssen Pharmaceutica N.V
| | - Ed Cleator
- Chemical Process R&D, External R&D Capabilities, Janssen Pharmaceutica N.V
| |
Collapse
|
3
|
Pham QH, Tague AJ, Richardson C, Hyland CJT, Pyne SG. The Pd-catalysed asymmetric allylic alkylation reactions of sulfamidate imines. Chem Sci 2021; 12:12695-12703. [PMID: 34703555 PMCID: PMC8494038 DOI: 10.1039/d1sc03268b] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Accepted: 08/17/2021] [Indexed: 11/30/2022] Open
Abstract
The Pd-catalysed asymmetric allylic alkylation (Pd-AAA) of prochiral enamide anions derived from 5H-oxathiazole 2,2-dioxides has been developed. Various 4,5-disubstituted and 4-substituted cyclic sulfamidate imines have participated in the transformation with a range of allyl carbonates-as well as 2-vinyl oxirane, 2-vinyl-N-tosylaziridine, and 2-vinyl-1,1-cyclopropane dicarboxylate-to furnish the desired C-allylated products in moderate to high yields, with high regioselectivites and generally high enantioselectivities. Conversion between N- and C-allyl products was observed, with the N-allylated products converting to the C-allylated products over time. The resulting high-value allylated heterocyclic products all bear a tetrasubstituted stereogenic centre and can be reduced to an allylated chiral sulfamidate or an amino alcohol.
Collapse
Affiliation(s)
- Quoc Hoang Pham
- School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong Wollongong New South Wales 2522 Australia
| | - Andrew J Tague
- School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong Wollongong New South Wales 2522 Australia
| | - Christopher Richardson
- School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong Wollongong New South Wales 2522 Australia
| | - Christopher J T Hyland
- School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong Wollongong New South Wales 2522 Australia
| | - Stephen G Pyne
- School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong Wollongong New South Wales 2522 Australia
| |
Collapse
|
4
|
Pham QH, Hyland CJT, Pyne SG. Five-membered cyclic sulfamidate imines: versatile scaffolds for organic synthesis. Org Biomol Chem 2020; 18:7467-7484. [PMID: 32930695 DOI: 10.1039/d0ob01568g] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
In recent years, five-membered ring cyclic sulfamidate imines (5H-1,2,3-oxathiazole 2,2-dioxides) have received increasing attention as useful precursors for the stereoselective synthesis of many valuable heterocycles. Bearing a reactive N-sulfonyl imine moiety as part of the stereodefined skeleton, this sulfamidate imine platform has been utilised as a substrate in many reactions, including nucleophilic additions and reductions, to prepare highly functionalised cyclic sulfamidates. In addition, cyclic sulfamidate imines can also readily participate as nucleophiles in many chemical transformations, owing to the acidic proton(s) adjacent to the imine moiety. This short review highlights recent developments involving cyclic sulfamidate imines, including their synthesis and reactivity, with a focus on stereoselective processes.
Collapse
Affiliation(s)
- Quoc Hoang Pham
- School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong, New South Wales 2522, Australia.
| | | | | |
Collapse
|
5
|
Molla MR, Das P, Guleria K, Subramanian R, Kumar A, Thakur R. Cyanomethyl Ether as an Orthogonal Participating Group for Stereoselective Synthesis of 1,2- trans-β- O-Glycosides. J Org Chem 2020; 85:9955-9968. [PMID: 32600042 DOI: 10.1021/acs.joc.0c01249] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Stereoselective formation of glycosidic linkages has been the prime focus for contemporary carbohydrate chemistry. Herein, we report cyanomethyl (CNMe) ether as an efficient and effective participating orthogonal protecting group for the stereoselective synthesis of 1,2-trans-β-O-glycosides. The participating group facilitated good to high β-selective glycosylation with a broad range of electron-rich and electron-deficient glycosyl acceptors. Detailed experimental and theoretical studies reveal the involvement of CNMe ether in the formation of a six-membered imine-type cyclic intermediate for the observed stereoselectivity. Rapid incorporation and selective removal of the CNMe ether group in the presence of benzyl ether and isopropylidene acetal protection have also been reported here. The nitrile group provided an opportunity for the glycodiversification through further derivatizations.
Collapse
Affiliation(s)
- Mosidur Rahaman Molla
- Department of Chemistry, National Institute of Technology Patna, Patna, Bihar 800005, India
| | - Pradip Das
- Department of Chemistry, National Institute of Technology Patna, Patna, Bihar 800005, India
| | - Kanika Guleria
- Department of Chemistry, Indian Institute of Technology Patna, Patna, Bihar 801103, India
| | - Ranga Subramanian
- Department of Chemistry, Indian Institute of Technology Patna, Patna, Bihar 801103, India
| | - Amit Kumar
- Department of Chemistry, Indian Institute of Technology Patna, Patna, Bihar 801103, India
| | - Rima Thakur
- Department of Chemistry, National Institute of Technology Patna, Patna, Bihar 800005, India
| |
Collapse
|
6
|
Zinad DS, Mahal A, Mohapatra RK, Sarangi AK, Pratama MRF. Medicinal chemistry of oxazines as promising agents in drug discovery. Chem Biol Drug Des 2019; 95:16-47. [DOI: 10.1111/cbdd.13633] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 09/02/2019] [Accepted: 09/04/2019] [Indexed: 12/18/2022]
Affiliation(s)
- Dhafer S. Zinad
- Applied Science Department University of Technology Baghdad Iraq
| | - Ahmed Mahal
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization and Guangdong Provincial Key Laboratory of Applied Botany South China Botanical Garden Chinese Academy of Sciences Guangzhou China
- Guangzhou HC Pharmaceutical Co., Ltd. Guangzhou China
| | - Ranjan K. Mohapatra
- Department of Chemistry Government College of Engineering Keonjhar Odisha India
| | - Ashish K. Sarangi
- Department of Chemistry Government College of Engineering Keonjhar Odisha India
| | - Mohammad Rizki Fadhil Pratama
- Department of Pharmacy Faculty of Health Sciences Muhammadiyah University of Palangkaraya Palangka Raya Indonesia
- Department of Pharmaceutical Chemistry Faculty of Pharmacy Airlangga University Surabaya Indonesia
| |
Collapse
|
8
|
Gijsen HJM, Alonso de Diego SA, De Cleyn M, García-Molina A, Macdonald GJ, Martínez-Lamenca C, Oehlrich D, Prokopcova H, Rombouts FJR, Surkyn M, Trabanco AA, Van Brandt S, Van den Bossche D, Van Gool M, Austin N, Borghys H, Dhuyvetter D, Moechars D. Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate. J Med Chem 2018; 61:5292-5303. [PMID: 29809004 DOI: 10.1021/acs.jmedchem.8b00304] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the p Ka of the amidine group, resulting in compound 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF. However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression. Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition. This has led to compound 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clinical trials.
Collapse
Affiliation(s)
- Harrie J M Gijsen
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Sergio A Alonso de Diego
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen-Cilag SA , C/Jarama 75A , 45007 Toledo , Spain
| | - Michel De Cleyn
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Aránzazu García-Molina
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen-Cilag SA , C/Jarama 75A , 45007 Toledo , Spain
| | - Gregor J Macdonald
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Carolina Martínez-Lamenca
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Daniel Oehlrich
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Hana Prokopcova
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Frederik J R Rombouts
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Michel Surkyn
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Andrés A Trabanco
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen-Cilag SA , C/Jarama 75A , 45007 Toledo , Spain
| | - Sven Van Brandt
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Dries Van den Bossche
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Michiel Van Gool
- Neuroscience Medicinal Chemistry, Janssen Research & Development , Janssen-Cilag SA , C/Jarama 75A , 45007 Toledo , Spain
| | - Nigel Austin
- Discovery Sciences, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Herman Borghys
- Discovery Sciences, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Deborah Dhuyvetter
- Discovery Sciences, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| | - Diederik Moechars
- Neuroscience Biology, Janssen Research & Development , Janssen Pharmaceutica NV , Turnhoutseweg 30 , B-2340 Beerse , Belgium
| |
Collapse
|